West Pharmaceutical Services started at buy by Citi
| WST Stock | USD 345.00 1.01 0.29% |
Slightly above 53% of West Pharmaceutical's investor base is interested to short. The analysis of overall sentiment of trading West Pharmaceutical Services stock suggests that many investors are impartial at this time. West Pharmaceutical's investing sentiment can be driven by a variety of factors including economic data, West Pharmaceutical's earnings reports, geopolitical events, and overall market trends.
West |
Citi has initiated coverage of West Pharmaceutical Services , a provider of pharmaceutical packaging and injectable solutions, with a buy rating. Read more here.
Read at seekingalpha.com
 |
West Pharmaceutical Fundamental Analysis
We analyze West Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of West Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of West Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
West Pharmaceutical is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
West Pharmaceutical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with West Pharmaceutical stock to make a market-neutral strategy. Peer analysis of West Pharmaceutical could also be used in its relative valuation, which is a method of valuing West Pharmaceutical by comparing valuation metrics with similar companies.
Peers
West Pharmaceutical Related Equities
| ICUI | ICU Medical | 3.10 | ||||
| COO | Cooper Companies, | 2.11 | ||||
| BAX | Baxter International | 1.95 | ||||
| BDX | Becton Dickinson | 1.24 | ||||
| MMSI | Merit Medical | 0.94 | ||||
| RMD | ResMed | 0.65 | ||||
| HOLX | Hologic | 0.45 | ||||
| TFX | Teleflex Incorporated | 0.13 | ||||
| ALC | Alcon AG | 0.17 | ||||
| EMBC | Embecta Corp | 0.89 | ||||
| RGEN | Repligen | 1.20 | ||||
| HAE | Haemonetics | 2.80 |
Additional Tools for West Stock Analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.